Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:250865.
doi: 10.1155/2013/250865. Epub 2013 May 9.

Zolpidem in progressive supranuclear palsy

Sandip K Dash  1
Affiliations

Zolpidem in progressive supranuclear palsy

Sandip K Dash. Case Rep Neurol Med. 2013.

Abstract

Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder. Reduced neurotransmission of GABA in the striatum and globus pallidus may contribute to the symptoms of motor and cognitive symptoms seen in PSP. Zolpidem is a GABA agonist of the benzodiazepine subreceptor BZ1. Here a nondiabetic, normotensive case of PSP is (Progressive Supranuclear Palsy) described, which showed improvement in swallowing, speech, and gaze paresis after zolpidem therapy and possible mechanism of actions are discussed. However, more trials are needed with large number of patients to confirm the effectiveness of zolpidem in progressive supranuclear palsy.

PubMed Disclaimer

References

    1. Gerhard A, Trender-Gerhard I, Turkheimer F, Quinn NP, Bhatia KP, Brooks DJ. In vivo imaging of microglial activation with [11C]-PK11195 PET progresive supranuclear palsy. Movement Disorders. 2006;21(1):89–93. - PubMed
    1. Levy R, Ruberg M, Herrero MT, et al. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. Neurology. 1995;45(1):127–134. - PubMed
    1. Daniele A, Moro E, Bentivoglio AR. Zolpidem in progressive supranuclear palsy. The New England Journal of Medicine. 1999;341(7):543–544. - PubMed
    1. Mayer BJ, Bonelli RM, Niederwieser G, et al. Zolpidem in progressive supra nuclear palsy. European Journal of Neurology. 2002;9:184–185. - PubMed
    1. Cotter C, Armytage T, Crimmins D. The use of zolpidem in the treatment of progressive supranuclear palsy. Journal of Clinical Neuroscience. 2010;17(3):385–386. - PubMed

LinkOut - more resources